COVID-19 epidemiology update Download page in .pdf format

Summary of COVID-19 cases, hospitalizations and deaths, testing and variants of concern across Canada and over time.

Current update Archived reports

Current update

Updated:

This summary of COVID-19 cases across Canada contains detailed data about the spread of the virus over time and in different regions of the country. Includes breakdowns by age and sex or gender. Provides an overview of testing, variants of concern, cases following vaccination and severe illness and outcomes.

Update schedule: We update all sections of this page every Friday, except for 'Cases following vaccination', which we update on Tuesdays.

Changes to update schedule

On June 10, 2022, we changed this page to reflect current reporting by the provinces and territories. We’ve switched from daily to weekly updates for cases, deaths and laboratory tests in the following sections: Key updates, Current situation and National overview.

Key COVID-19 updates (Last data update )

Weekly change in cases

{Weekly cases}

Total cases

{Total cases}

Weekly change in deaths

{Weekly deaths}

Total deaths

{Total deaths}

Total tests performed

{Total tests performed}

Daily percent positive (last 7 days)

{Daily percent positive (last 7 days)}%

Daily tests per 100,000 population (last 7 days)

{Daily tests per 100,000 population (last 7 days)}

Notes

Key COVID-19 updates: Text description

Key COVID-19 updates (Last data update )
Weekly change in cases	{Weekly cases}
Total cases	{Total cases}
Weekly change in deaths	{Weekly deaths}
Total deaths	{Total deaths}
Total tests performed	{Tests performed today}
Daily percent positive (last 7 days)	{Daily percent positive (last 7 days)}%
Daily tests per 100,000 population (last 7 days)	{Rate tests}

Current situation

Figure 1a. Types of statistics of Types of measures of COVID-19, Types of statistics (Last data update )

Hover over or tap regions to see cases, and deaths and tests performed in Canada over time. Click the play button to animate the map. Map data is available in .csv and .json formats and data dictionaries for cases and deaths .csv and for lab indicators .csv.

The count of total cases in Canada reported to ISC was 1,471per 100,000 population.

Download data in .csv format

Notes

Figure 1a: Text description

Areas in Canada with cases of COVID-19
Location	Total cases		Cases (latest week)		Cases (latest 2 weeks)		Total deaths		Deaths (latest week)		Deaths (latest 2 weeks)		Total tests performed	Moving average daily tests performed (latest week)		Moving average daily percent positivity (latest week)
Location	Count	Rate^*	Count	Rate^*	Count	Rate^*	Count	Rate^*	Count	Rate^*	Count	Rate^*	Count	Count	Rate^*	Percent

^* Rate per 100,000 population
Out of the total number of people tested, 76 were repatriated travellers, of which 13 were cases.

Health regions in Canada with cases of COVID-19
Province	Health Region	Total cases		Cases last 14 days		Total deaths		Deaths last 14 days
Province	Health Region	Count	Rate^*	Count	Rate^*	Count	Rate^*	Count	Rate^*

^‡ No data is available for this day, and so the most recently available data is displayed.

^† Rate per 1,000,000 population

^* Rate per 100,000 population

Note: Out of the total number of people tested, 76 were repatriated travellers, of which 13 were cases.

Figure 1b. Types of statistics of types of measures of COVID-19 in Canada (Last data update )

The figures below show cases over time. The range of dates (January 31st, 2020 - present date) is the same for each figure. This allows you to compare the provinces and territories on the same timescale.

Notes

Figure 1b: Text description

Downloadable data (in .csv format).

National overview

There have been (Num tests} COVID-19 tests performed in Canada or 1,620,777 tests per 1 million people.

Table 1. Weekly* change in the number of cases, deaths and tests performed, by province or territory, (Last data update )
Location	Cases	Deaths	Tests performed

Notes

^* Weekly change in cases, deaths and tests performed reflect the changes in the case and death counts between the end of the latest week and the end of the previous week. Data are updated on an ongoing basis. The current report reflects data most recently received by PHAC at the time of the last update and are subject to change.
N/A means that no update was provided by the province or territory for the latest week.
Due to changes in COVID-19 testing policies in many jurisdictions since December 2021, case counts are under-estimated.
Starting April 7, 2022, British Columbia reports all deaths within 30 days of a positive COVID-19 test, regardless of the cause of death. As a result, deaths are now over-estimated for BC and should not be directly compared to other jurisdictions or to earlier data from BC.
As of June 30th, 2022 Saskatchewan publishes monthly COVID-19 updates. Weekly data for cases, and deaths after June 25^th, 2022 are not available.

COVID-19 variants in Canada

All viruses, including COVID-19, change over time. These changes are called mutations, and result in variants of the virus. Not all mutations are of concern. Most do not cause more severe illness. However, some mutations result in variants of concern or variants of interest.

A variant of concern has mutations that are significant to public health. Before a variant of interest is considered one of concern, scientists and public health professionals must determine if the mutations result in an actual change in the behaviour of the virus. For example, it might:

spread more easily
cause more severe illness
require different treatments, or
reduce vaccine effectiveness

There are several variants of interest that have mutations similar to variants of concern, but we don’t yet know if they pose a higher risk to public health.

The Public Health Agency of Canada (PHAC) works with provincial and territorial partners and the Canadian COVID-19 Genomics Network (CanCOGeN) to sequence a percentage of all positive COVID-19 test results. Sequencing reveals the genetic code of the virus, which tells us which variant is involved in a specific case of COVID-19. We report the proportion of COVID-19 variants in Canada every week.

We collect evidence to determine if new variants meet the definition for a variant of concern or a variant of interest. Many variants are being tracked across Canada and around the world. Variants of concern now represent a majority of COVID-19 cases in Canada.

Current variants of concern in Canada include:

Alpha (B.1.1.7)
Beta (B.1.351)
Gamma (P.1)
Delta (B.1.617.2)
Omicron (B.1.1.529)

New variants will continue to appear. We must remain vigilant and take all available measures to limit spread.

Figure 2. Weekly variant breakdown Updated: December 31, 2021, 4 pm EDT download weekly variant breakdown data in .csv format

The graphic shows the percentage mix of COVID-19 variants detected in Canada through whole genome sequencing, by week of sample collection. You can see the numbers for each date by hovering over, tabbing to, or long-pressing any of the bars. To see a specific variant or variant grouping, click or press return. Repeat to restore the complete graph. Sublineages or offshoots for some variants can be revealed or hidden by clicking on the name of the variant in the legend.

This information is based on whole genome sequencing from surveillance testing in all provinces and territories. In addition to sequencing done by the National Microbiology Laboratory in Winnipeg, data is included from provincial and territorial laboratories.

Sequencing takes from 1 to 3 weeks to complete, so the proportions for recent weeks may change as more data are added. Surveillance in each province or territory is organized and prioritized according to local needs and may change from time to time. Because of differences in local sampling and reporting, the percentages illustrate trends rather than precise measurements.

Weekly variant breakdown

Percentage of COVID-19 cases identified through whole genome sequencing, presented by variant and by week of sample collection.

Figure 2: Text description

Variant Grouping

Note: The shaded columns on the right represent a period of accumulating data.

Contributing laboratories:

National Microbiology Laboratory (NML) - supplemental sequencing for all provinces and territories

Detailed case information

The tables and figures below reflect detailed case information provided to the Public Health Agency of Canada (PHAC) by health authorities in the provinces and territories. This data is updated every week. It may change as we get more information about cases.

Updated: June 25, 2021, 9 am EST

Epidemic curve

As of June 25, 2021, 9 am EST, PHAC has received detailed case report data on cases.

The shaded area on the far right of Figure 3 represents a period of accumulating data. This is the period of time (1 to 2 weeks) before the latest cases are reported to PHAC. This delay is a result of the time required to seek health care, get tested and receive results. It also takes time for public health authorities to gather information on cases. We update this information as it becomes available.

Figure 3. COVID-19 cases (n=^{Footnote 1}) in Canada by date^{Footnote 2} as of ()

Figure 3. COVID-19 cases (n=^{Footnote 1}) in Canada by date^{Footnote 2} as of (total cases)

Figure 3. COVID-19 cases (n=^{Footnote 1}) in Canada by date^{Footnote 2} as of (by age - 10 year groups)

Figure 3. COVID-19 cases (n=^{Footnote 1}) in Canada by date^{Footnote 2} as of (by age - 20 year groups)

Figure 3: Text description

COVID-19 cases (n=^{Footnote 1}*) in Canada by date^{Footnote 2} as of
Date^{Footnote 2}	0-11	12-19	20-29	30-39	40-49	50-59	60-69	70-79	80+

COVID-19 cases (n=^{Footnote 1}*) in Canada by date^{Footnote 2} as of
Date^{Footnote 2}	0-19	20-39	40-59	60-79	80+

Demographics

We have detailed case report data from 99,853 cases. We know the age of patients in 99.78% of cases, and both age and gender in 99.98% of cases.

Of the cases reported in Canada so far, {Percent Gender} were {Gender} and {Percent of Over 60} were between 20 and 39 years old (Figure 4).

Figure 4. distribution of COVID-19 cases (n=^{Footnote 1}) in Canada as of ^{Footnote 3}

Figure 4: Text description

Age by gender^{Footnote 3} distribution of COVID-19 cases (n=^{Footnote 1}) in Canada,
Age group (years)	Number of cases with case reports (percentage)	Number of male cases (percentage)	Number of female cases (percentage)	Number of other cases (percentage)

Cases following vaccination

Data extracted on for cases between December 14, 2020 and .

Changes to update schedule

We’ve adjusted our update schedule to reflect changes in how often this data is reported to us.

“Cases following vaccination rate ratio indicators” are updated every 4 weeks.
“Case counts” and “distributions of cases following vaccination” are updated weekly.

While COVID-19 vaccines are highly effective at preventing severe outcomes such as hospitalization and death, vaccinated people can still get infected if exposed. This means that even with high vaccine effectiveness, some vaccinated people will get sick, be hospitalized or die.

Most people in Canada have been vaccinated. Because they’re a larger group, there will naturally be more cases among vaccinated people than among unvaccinated people. However, despite their higher case counts, vaccinated people are less likely to get very sick or die.

Case counts underestimate the total number of COVID-19 cases because a rapid increase in cases starting in December 2021 led to changes in COVID-19 testing policies and delays in data entry.

Case counts are likely to over-represent people at risk of severe disease, because they have been prioritized for testing. Data should be interpreted with caution.

Cases reported since the start of the vaccination campaign, as of July 03, 2021

The vaccination campaign began on December 14, 2020. Since then, we've received case-level vaccine history data for 75.5% (n=624,980) of known COVID-19 cases aged 5 and older.

Of these cases:

() were unvaccinated
() had completed their primary vaccine series
() had completed their primary vaccine series and 1 additional dose
() had completed their primary vaccine series and 2 or more additional doses

For definitions of the different vaccination statuses, please refer to the Technical notes and definitions section.

Figure 5. of confirmed COVID-19 cases reported to PHAC by vaccination status as of July 10, 2021

Figure 5: Text description

Outcomes of confirmed COVID-19 cases reported to PHAC by vaccination status, as of July 10, 2021
Status	Cases	Hospitalizations	Deaths

July 10, 2021.

Cases following vaccination were more common among older adults and females (Table 2). This may be due to:

higher risk of disease among older adults and pregnant people
longer life expectancy among females, which means more women move into older age groups with a higher risk of disease

Older adults have been prioritized for second booster doses. As a result, older people make up a large proportion of people who had completed their primary vaccine series and 2 or more additional doses. For the same reason, they also make up a large proportion of cases in that group.

Source: Detailed case information received by PHAC from provinces and territories, since December 14, 2020 (see data notes in the Technical notes and definitions section)

People who were diagnosed with COVID-19 after completing their primary vaccine series were significantly less likely to be hospitalized or to die, particularly if they received an additional dose(s).

Between and , unvaccinated cases were times more likely to be hospitalized and times more likely to die from their illness, compared to cases with a completed primary vaccine series. During the same 4-week period, unvaccinated cases were times more likely to be hospitalized and times more likely to die from their illness, compared to cases with a completed primary vaccine series and 1 or more additional doses (see data notes in Technical notes and definitions section).

Technical notes and definitions

Data for this analysis comes from the COVID-19 national data set, which contains detailed case-level information received by PHAC from all provinces and territories.

Data notes for Table 2

12 of 13 provinces and territories have reported case-level vaccine history data to PHAC as part of the national COVID-19 dataset.
of these provinces and territories reported data on cases with a completed primary vaccine series and 1 additional dose. of the 12 provinces and territories reported data on cases with a completed primary vaccine series and 2 or more additional doses. In provinces and territories that have not yet reported additional dose data, cases are classified as having completed their primary vaccine series if they have a completed primary series or with or without any more additional doses.
We used a data cut-off of to account for routine reporting delays associated with vaccine history information.
^†Counts of cases by vaccination status may not add up to total counts, as data on cases not yet protected and partially vaccinated cases are not presented here.
Data presented here on cases with a completed primary vaccine series and 1 or more additional dose(s) are limited to individuals aged 12 years or older. Eligibility for booster dose programs varies across provinces and territories.
^*When available, we used gender data. If unavailable, we used sex data. We excluded cases with missing gender and sex data from the gender analysis. Reliable data on gender diverse respondents are unavailable due to small counts.

Data notes for 4-week age standardized rate ratios

Rate ratios are age-standardized using July 2021 Canadian population estimates.
For analyses of rate ratios, cases are classified as having completed their primary series with one or more additional dose(s) if they have received at least 1 additional dose after completing their primary series
Rate ratio calculations were based on data from provinces and territories that have reported complete case-level vaccine history data to PHAC during the 4-week period of analysis.

Vaccine status definitions

Episode date: Refers to symptom onset date. When symptom onset date is unavailable or the case is asymptomatic, episode date refers to either:

laboratory specimen collection date, or
laboratory testing date

PHAC monitors cases following vaccination using the following categories:

Unvaccinated cases: those who were unvaccinated at the time of their episode date.
Cases not yet protected from vaccination: those whose episode date occurred less than 14 days after their first dose of the vaccine.
Partially vaccinated cases: those whose episode date occurred:
- 14 days or more after their first vaccine dose in a 2-dose series, or
- less than 14 days after their second dose of the vaccine.
Cases with a completed primary series: those whose episode date occurred:
- 14 days or more after receipt of a second dose in a 2-dose series, or
- 14 days or more after receipt of one dose of a 1-dose vaccine series, and
- if an additional (for example, third dose or booster) dose was received, 0 to <14 days after receipt of the first additional dose.
Cases with a completed primary series and 1 or more additional dose(s): those whose episode date occurred 14 days or more following the receipt of at least 1 additional dose (for example, third dose or booster) of a COVID-19 vaccine product, after completing a primary vaccine series.
- Data on counts and distributions are further categorized into 2 groups:
  - Cases with a completed primary vaccine series and 1 additional dose: those whose episode date occurred 14 days or more following receipt of 1 additional dose (for example, third dose or first booster) of a COVID-19 vaccine product and, if a second additional dose was received, 0 to <14 days after receipt of that dose
  - Cases with a completed primary series and 2 or more additional doses: those whose episode date occurred 14 days or more following receipt of at least 2 additional doses (for example, fourth dose or second booster)
COVID-19 vaccine product: vaccines that have been:
- authorized by Health Canada or
- accepted by the Government of Canada for the purpose of travel to and within Canada

Severe illness and outcomes

Hospital use

Figure 6. Daily number of hospital beds and ICU beds occupied by COVID-19 patients as of

Download hospitalization, ICU and mechnical ventilation data in .csv format

Figure 6: Text description

Daily Census of COVID-19 Patients who were hospitalized, vented or in the ICU as of
Date	Total patients hospitalized	Patients hospitalized in non-ICU	Patients in the ICU	Patients who were mechanically vented

Between October 10 and Oct 17:

the total number of hospital beds occupied by COVID-19 patients increased from to beds.
the number of non-ICU beds occupied by COVID-19 patients increased from to beds.
the number of ICU beds occupied by COVID-19 patients increased from to beds.
the number of COVID-19 patients who were mechanically vented increased from to .

Hospitalizations and deaths to date

We have detailed case report data on 99,853 cases, and hospitalization status for 65,597 (xx%) of them:

{Num Hospitalized} cases ({Percent Hospitalized}%) were hospitalized, of whom:

{Num Intensive Care} ({Percent Intensive Care}%) were admitted to the ICU

The provinces and territories provided detailed case report forms for {Num Deaths} deaths related to COVID-19.

Figure 7. Age and gender^{Footnote 3} distribution of COVID-19 cases in Canada as of (n=^{Footnote 1})

Figure 7a. Age and gender^{Footnote 3} distribution of COVID-19 cases hospitalized in Canada as of (n=^{Footnote 1})

Figure 7b. Age and gender^{Footnote 3} distribution of COVID-19 cases admitted to ICU in Canada as of (n=^{Footnote 1})

Figure 7c. Age and gender^{Footnote 3} distribution of COVID-19 cases deceased in Canada as of (n=^{Footnote 1})

Data note: Figure 7 includes COVID-19 cases hospitalized, admitted to ICU, and deceased for which age and gender information were available. Therefore, some COVID-19 hospitalizations, ICU admissions, and deaths may not be included in Figure 7.

Figure 7: Text description

Age and gender^{Footnote 4} distribution of COVID-19 cases hospitalized in Canada as of (n=^{Footnote 1})
Age group (years)	Number of cases with case reports (percentage)	Number of male cases (percentage)	Number of female cases (percentage)	Number of other cases (percentage)

Age and gender^{Footnote 4} distribution of COVID-19 cases admitted to ICU in Canada as of (n=^{Footnote 1})
Age group (years)	Number of cases with case reports (percentage)	Number of male cases (percentage)	Number of female cases (percentage)	Number of other cases (percentage)

Age and gender^{Footnote 4} distribution of COVID-19 cases deceased in Canada as of (n=^{Footnote 1})
Age group (years)	Number of cases with case reports (percentage)	Number of male cases (percentage)	Number of female cases (percentage)	Number of other cases (percentage)

Provincial, territorial and international reporting

For more information, please refer to provincial or territorial COVID-19 webpages:

Footnote 1

This figure is based on cases for which a case report form was received by the Public Health Agency of Canada from provincial or territorial partners.

Return to first footnote 1 referrer

Footnote 2

The shaded area represents a period of accumulating data where it is expected that cases have occurred but have not yet been reported nationally. The earliest of the following dates were used as an estimate: Onset date, Specimen Collection Date, Laboratory Testing Date, Date Reported to Province or Territory, or Date Reported to PHAC.

Return to first footnote 2 referrer

Footnote 3

Where available, gender data was used; when gender data was unavailable, sex data was used. Reliable data on gender diverse respondents are unavailable due to small counts.

Return to first footnote 3 referrer

Additional COVID-19 data resources

Download cases and deaths data (.csv) and lab indicators data (.csv)

Download cases and deaths data dictionary (.csv) and lab indicators data dictionary (.csv)

Download report (.pdf)

To learn more, visit COVID-19 data trends

Report a problem or mistake on this page

Date modified:: 2021-05-28

Language selection

Search

COVID-19 epidemiology update Download page in .pdf format

Current update

Changes to update schedule

On this page

Key COVID-19 updates (Last data update )

Current situation

Figure 1a. Types of statistics of Types of measures of COVID-19, Types of statistics (Last data update )

No Trend Data Available

Figure 1b. Types of statistics of types of measures of COVID-19 in Canada (Last data update )

National overview

COVID-19 variants in Canada

Figure 2. Weekly variant breakdown Updated: December 31, 2021, 4 pm EDT download weekly variant breakdown data in .csv format

Contributing laboratories:

Detailed case information

Epidemic curve

Figure 3. COVID-19 cases (n=^{Footnote 1}) in Canada by date^{Footnote 2} as of ()

Figure 3. COVID-19 cases (n=^{Footnote 1}) in Canada by date^{Footnote 2} as of (total cases)

Figure 3. COVID-19 cases (n=^{Footnote 1}) in Canada by date^{Footnote 2} as of (by age - 10 year groups)

Figure 3. COVID-19 cases (n=^{Footnote 1}) in Canada by date^{Footnote 2} as of (by age - 20 year groups)

Demographics

Figure 4. distribution of COVID-19 cases (n=^{Footnote 1}) in Canada as of ^{Footnote 3}

Cases following vaccination

Changes to update schedule

Cases reported since the start of the vaccination campaign, as of July 03, 2021

Figure 5. of confirmed COVID-19 cases reported to PHAC by vaccination status as of July 10, 2021

Technical notes and definitions

Severe illness and outcomes

Hospital use

Figure 6. Daily number of hospital beds and ICU beds occupied by COVID-19 patients as of

Hospitalizations and deaths to date

Figure 7. Age and gender^{Footnote 3} distribution of COVID-19 cases in Canada as of (n=^{Footnote 1})

Figure 7a. Age and gender^{Footnote 3} distribution of COVID-19 cases hospitalized in Canada as of (n=^{Footnote 1})

Figure 7b. Age and gender^{Footnote 3} distribution of COVID-19 cases admitted to ICU in Canada as of (n=^{Footnote 1})

Figure 7c. Age and gender^{Footnote 3} distribution of COVID-19 cases deceased in Canada as of (n=^{Footnote 1})

Provincial, territorial and international reporting

Additional COVID-19 data resources

COVID-19 epidemiology update Download page in .pdf format

Current update

Changes to update schedule

On this page

Key COVID-19 updates (Last data update )

Current situation

No Trend Data Available

National overview

COVID-19 variants in Canada

Figure 2. Weekly variant breakdown Updated: December 31, 2021, 4 pm EDT download weekly variant breakdown data in .csv format

Contributing laboratories:

Detailed case information

Epidemic curve

Figure 3. COVID-19 cases (n=Footnote 1) in Canada by dateFootnote 2 as of ( total cases by age - 10 year groups by age - 20 year groups )

Figure 3. COVID-19 cases (n=Footnote 1) in Canada by dateFootnote 2 as of (total cases)

Figure 3. COVID-19 cases (n=Footnote 1) in Canada by dateFootnote 2 as of (by age - 10 year groups)

Figure 3. COVID-19 cases (n=Footnote 1) in Canada by dateFootnote 2 as of (by age - 20 year groups)

Demographics

Figure 4. Age Age by gender distribution of COVID-19 cases (n=Footnote 1) in Canada as of Footnote 3

Cases following vaccination

Changes to update schedule

Cases reported since the start of the vaccination campaign, as of July 03, 2021

Figure 5. Distribution Number of confirmed COVID-19 cases reported to PHAC by vaccination status as of July 10, 2021

Technical notes and definitions

Severe illness and outcomes

Hospital use

Figure 6. Daily number of hospital beds and ICU beds occupied by COVID-19 patients as of

Hospitalizations and deaths to date

Figure 7. Age and genderFootnote 3 distribution of COVID-19 cases hospitalized admitted to ICU deceased in Canada as of (n=Footnote 1)

Figure 7a. Age and genderFootnote 3 distribution of COVID-19 cases hospitalized in Canada as of (n=Footnote 1)

Figure 7b. Age and genderFootnote 3 distribution of COVID-19 cases admitted to ICU in Canada as of (n=Footnote 1)

Figure 7c. Age and genderFootnote 3 distribution of COVID-19 cases deceased in Canada as of (n=Footnote 1)

Provincial, territorial and international reporting

Additional COVID-19 data resources

Figure 3. COVID-19 cases (n=^{Footnote 1}) in Canada by date^{Footnote 2} as of ()

Figure 3. COVID-19 cases (n=^{Footnote 1}) in Canada by date^{Footnote 2} as of (total cases)

Figure 3. COVID-19 cases (n=^{Footnote 1}) in Canada by date^{Footnote 2} as of (by age - 10 year groups)

Figure 3. COVID-19 cases (n=^{Footnote 1}) in Canada by date^{Footnote 2} as of (by age - 20 year groups)

Figure 4. distribution of COVID-19 cases (n=^{Footnote 1}) in Canada as of ^{Footnote 3}

Figure 5. of confirmed COVID-19 cases reported to PHAC by vaccination status as of July 10, 2021

Figure 7. Age and gender^{Footnote 3} distribution of COVID-19 cases in Canada as of (n=^{Footnote 1})

Figure 7a. Age and gender^{Footnote 3} distribution of COVID-19 cases hospitalized in Canada as of (n=^{Footnote 1})

Figure 7b. Age and gender^{Footnote 3} distribution of COVID-19 cases admitted to ICU in Canada as of (n=^{Footnote 1})

Figure 7c. Age and gender^{Footnote 3} distribution of COVID-19 cases deceased in Canada as of (n=^{Footnote 1})